News

‘14 private cord blood banks approved, functioning’

Our Bureau New Delhi | Updated on March 12, 2018 Published on May 10, 2015

About 30,000 bio-specimens collected from 24,533 patients



The Centre has no plans to set up tissue banks in the country, the Health Ministry has said, adding that there are 14 approved umbilical cord blood banks operating in the country, all of them in the private sector.

Replying to a question by K Parasuraman (AIADMK) in the Lok Sabha last week, Minister of State for Health, Sripad Yesso Naik, said the Indian Council of Medical Research had set up a National Tumour Tissue Repository at the Tata Memorial Hospital, Mumbai, in 2005.

Bio-specimens

“A total of 29,993 bio-specimens have been collected from 24,533 patients in the hospital till February 2015. A total of 2,004 bio-specimens have been disbursed to 41 projects along with clinical and follow-up data of 994 patients,” he added.

Speaking about the 14 approved cord blood banks, he said that four of them were in Gurgaon, set up by Cryobank International, Lifecell International, Unistemk Biosciences and Totipotent RX Cell Therapy.

Maharashtra has three of them, approved cord blood banks by Reliance Life Sciences, Ree Laboratories and Regenerative Medical Services.

Karnataka and Gujarat have two each by Narayana Hrudayalaya, Cryo Save (India) and Stemcyte India, Best Wellcare Management Services, respectively.

Tamil Nadu, Andhra Pradesh and West Bengal have one cord blood bank each, set up by Lifecell International, PathCare Labs and Cord Life Sciences, respectively.

“Umbilical cord blood banks are regulated under the Drugs and Cosmetics Act and Rules 1945,” the Minister said.

Published on May 10, 2015

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
null
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.